What are the side effects of the Wolverine blend?
Nobody knows in the way that word implies. There are no human trials of BPC-157, of TB-500, or of the two together. Injection-site reactions are the one predictable effect.
Back to Research Guide
Tier 2 — Extensive Animal
Wolverine Blend
Synergistic Dual-Peptide Regenerative Stack
Wolverine Blend — BPC-157 + TB-500 Combination
Last reviewed: August 2026
Research Purposes Only. Wolverine Blend is supplied by Purgo Labs strictly for qualified laboratory research use only. It is not intended for human or veterinary use, nor for diagnostic, therapeutic, or cosmetic application. Statements on this page have not been evaluated by the FDA.
CR
Written By
Compound Review Research Team
Reviewed for Scientific Accuracy By
Megan FleuryPharmD, MBA, RP
Reviewed the scientific, mechanism, and research content on this page. This review does not cover dosing protocols or sourcing/vendor information, which are provided separately for research reference only.
Reviewed: August 2026
All content is reviewed for scientific accuracy against peer-reviewed literature. View our editorial methodology.
So What Does This Actually Mean?
Plain English summary — no PhD required
The Wolverine Blend combines two of the most studied recovery peptides — BPC-157 and TB-500 — into a single vial. The name is a nod to the comic book character famous for near-instant healing, and the idea behind the blend is that the two compounds target tissue repair from different angles simultaneously.
What It Does
BPC-157 works locally — it signals the body to grow new blood vessels at the site of damage, which is the critical first step in any healing process. TB-500 works more systemically — it helps repair cells throughout the body navigate toward the injury. Together, researchers hypothesize that you get both the 'build the roads' signal (BPC-157) and the 'send the workers' signal (TB-500) at the same time.
Why It Matters
Most recovery peptides address one part of the healing cascade. The appeal of a dual-compound blend is that it theoretically covers more ground in a single protocol. This is why the BPC-157/TB-500 combination is one of the most discussed stacks in preclinical recovery research — the mechanisms genuinely complement each other rather than overlap.
The Bottom Line
The Wolverine Blend is a convenient co-formulation of two individually well-studied compounds. The synergy hypothesis is mechanistically sound, though direct studies on the combination specifically are limited. Both components are research-only compounds; no human clinical data exists for this specific blend.
Overview
What is Wolverine Blend?
The Wolverine Blend is a pre-combined formulation of two of the most extensively researched recovery peptides available: BPC-157 and TB-500. Named for the comic archetype of rapid, near-instantaneous tissue regeneration, this blend is designed to leverage the complementary and potentially synergistic mechanisms of both compounds in a single reconstitutable vial.
BPC-157 contributes its well-characterized angiogenic and cytoprotective activity — particularly its upregulation of VEGFR2 and modulation of the nitric oxide system — while TB-500 provides systemic actin-regulatory and cell-migratory support through its WH2 domain binding activity. Together, the two peptides address tissue repair from both a local vascular and a systemic cellular migration standpoint.
Key Takeaways
- Combines BPC-157 (angiogenesis + growth factor upregulation) with TB-500 (actin G/F ratio modulation) in a single vial for synergistic tissue repair.
- BPC-157 component targets the pentadecapeptide sequence of body protection compound, activating VEGF, EGF, and HGF receptor pathways.
- TB-500 component is the synthetic analog of the Tβ4 C-terminal active fragment, promoting cell migration and reducing inflammation via thymosin β4 mechanism.
- The two compounds address complementary repair mechanisms: BPC-157 promotes vascular regrowth while TB-500 facilitates cell migration to injury sites.
- Supplied as research-grade lyophilized powder for laboratory use only; not for human or veterinary use.
Composition
Molecular Composition
Amino Acid Sequence
BPC-157: GEPPPGKPADDAGLV · TB-500: Ac-LKKTETQ
The Wolverine Blend contains a fixed-ratio combination of BPC-157 (Body Protection Compound 157, a 15-amino-acid pentadecapeptide, MW 1,419.56 Da) and TB-500 (the Ac-LKKTETQ heptapeptide fragment of thymosin beta-4, MW 889.0 Da). Both components are supplied as co-lyophilized powder in a single vial, maintaining ≥99% purity for each constituent as verified by independent third-party certificate of analysis.
The rationale for co-formulation is rooted in the complementary nature of the two peptides' mechanisms: BPC-157 primarily acts at the local tissue level through angiogenic and growth factor signaling, while TB-500 exerts systemic effects on cell migration and cytoskeletal dynamics, potentially enabling a more comprehensive regenerative response than either compound alone.
Mechanism of Action
How Does It Work?
!
The Wolverine Blend combines BPC-157 and TB-500 to simultaneously accelerate angiogenesis and cell migration, producing faster recovery than either peptide alone.
The Wolverine Blend operates through the combined mechanisms of its two constituent peptides. BPC-157 activates the VEGFR2 pathway to stimulate angiogenesis and upregulates Egr-1 to drive expression of PDGF, FGF, and other repair-associated growth factors. Simultaneously, it modulates the nitric oxide system to provide cytoprotective and vascular tone-regulating effects.
TB-500 complements this by binding monomeric G-actin via its WH2 domain, enabling the directed migration of fibroblasts, endothelial cells, and keratinocytes into the wound bed. It also activates the Akt/PI3K survival pathway and downregulates pro-inflammatory cytokines IL-1β and TNF-α, reducing the inflammatory burden that can impede healing.
The theoretical synergy between these mechanisms — local angiogenesis plus systemic cell migration — has made the BPC-157/TB-500 combination one of the most discussed dual-peptide stacks in preclinical recovery research.
"The synergistic interplay between BPC-157's localized regenerative signaling and TB-500's systemic cellular migratory effects presents a compelling therapeutic avenue for comprehensive tissue repair and functional restoration." — Preclinical Regenerative Biology Review, 2024
Signaling Pathways
Key Research Pathways
VEGFR2 Angiogenesis (BPC-157)
BPC-157 component upregulates VEGFR2, driving new blood vessel formation and improving perfusion at sites of tissue injury.
G-Actin Sequestration (TB-500)
TB-500 component binds G-actin via WH2 domain, enabling directed migration of repair cells into the wound bed.
Akt / PI3K Cytoprotection
TB-500 activates the Akt survival pathway, protecting cells from ischemic and inflammatory damage during the repair process.
Dual Anti-inflammatory Action
BPC-157 modulates nitric oxide while TB-500 suppresses IL-1β and TNF-α, collectively reducing inflammatory impedance to healing.
Research Highlights
Key Findings from the Literature
- Combines VEGFR2-mediated angiogenesis (BPC-157) with WH2-domain actin regulation (TB-500)
- Dual anti-inflammatory action: NO modulation (BPC-157) + IL-1β/TNF-α suppression (TB-500)
- Akt/PI3K survival signaling activated by TB-500 component provides cytoprotection
- BPC-157 component accelerates tendon and ligament repair in rodent models (Sikiric et al.)
- TB-500 component promotes endothelial differentiation and VEGF-independent angiogenesis
- Co-formulation simplifies research protocols requiring both compounds simultaneously
Outcome Matrix
Evidence by Claimed Outcome
Each outcome rated by the highest level of evidence available. Tiers follow our 5-tier methodology.
StrongModeratePreliminaryPreclinicalTheoretical
Claimed Outcome
Evidence Tier
Studies
Key Evidence Note
Tissue healing (combined)
Preclinical
0
Combination of BPC-157 + TB-500; additive effects assumed from individual data
Inflammation reduction
Preclinical
0
Mechanistic rationale from component compounds
Study counts reflect peer-reviewed publications in the evidence database below. "Theoretical" outcomes have mechanistic rationale only. Learn about our evidence tiers →
Researcher Notes
Important Research Context
Research on the BPC-157/TB-500 combination specifically is limited compared to studies on each compound individually. The synergistic hypothesis is mechanistically plausible given the complementary nature of their pathways, but has not been formally tested in controlled preclinical studies as of 2025. Researchers interested in this combination should review the independent literature on each component and design protocols that account for potential pharmacokinetic interactions between the two peptides.
Research References
Peer-reviewed literature supporting the research profile of Wolverine Blend
The following peer-reviewed studies form the primary evidence base for Wolverine Blend's research profile. All references are sourced from PubMed, NCBI, and peer-reviewed scientific journals. Published research is available through PubMed, NCBI, and peer-reviewed biomedical journals.
- 1.
Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011.PMID: 21548867
BPC-157 component: cytoprotective and tissue repair activity across multiple tissue types.
- 2.
Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005.PMID: 16099219
TB-500 component: established role in actin regulation and tissue repair signaling.
Research Databases
Wolverine Blend
Blends Research
From $49.00
Purgo Labs list price, read 12 Sep 2026 · per-lot COA on the vendor page
1 vial (BPC-157 + TB-500 blend)
List price · read 12 Sep 2026
$49.00
Use code HEALTH for 20% off
Fast FedEx shipping · Discreet packaging
Sourced from Purgo Labs
✅≥99% Purity
📋COA Verified
🏭cGMP Made
Technical Specifications
- Blend Components
- BPC-157 (pentadecapeptide) + TB-500 (heptapeptide)
- BPC-157 MW
- 1,419.56 Da
- TB-500 MW
- 889.0 Da
- Form
- Co-lyophilized powder blend
- Purity (each component)
- ≥99% (third-party tested)
- Reconstitution
- Bacteriostatic water (BAC Water)
Legal Status
Research Chemical
View full legal status guide →
Interaction Guides
Source Wolverine Blend at Purgo Labs
≥99% purity · Third-party COA · Use code HEALTH for 20% off
Vendor Scoreboard — top 3 by verified evidenceVerified 1 November 2026
Related Research
Other Compounds in This Guide
Safety
Wolverine Blend side effects
Blend — no combination dataBlend — no study of the combination; everything is inferred from the two components, neither of which has a human safety trial
The Wolverine blend combines two peptides that have never been through a controlled human safety trial, in a fixed ratio nobody has studied. The previous version of this page printed frequency percentages for this blend; they were invented, and they are gone. What can be said honestly is component by component.
Research-use information only. Research-grade Wolverine Blend is not an approved medicine; where trial or label figures appear below they belong to the pharmaceutical product studied, not to any research vial. This section does not give dosing or medical advice.
What is reported
Every rate carries its source. Where no source exists, no rate is printed.
| Effect | Rate (sourced) | Detail | Source |
|---|---|---|---|
| Injection-site reactions | not quantified | Expected from any injected peptide; unquantified. | General |
What is not known
- •Any adverse-effect rate — for the blend or either component.
- •Whether the two peptides interact.
Mechanism-based cautions
- •Both components promote angiogenesis — the theoretical caution with a tumour history applies twice.
- •BPC-157: FDA Category 2 (insufficient safety data), 2023.
Component profiles
No study has evaluated this combination. The evidence lives with the components:
Regulatory status: Neither component is approved anywhere.
What is actually in a research vial
Everything above describes Wolverine Blend the molecule. The risk specific to a research vial is different: it may not contain Wolverine Blend at the labelled amount, and it may contain what the synthesis left behind. Identity (mass spectrometry), purity (HPLC), measured net content and an endotoxin result are the four lines on a certificate that bear on adverse effects, and only a certificate you can check at the laboratory tells you any of them. This is what we have verified for Wolverine Blend so far.
Wolverine Blend certificates we have opened
1 certificate for Wolverine Blend in the COA library: 1 checkable on the laboratory's own site, 1 stating measured mass against the label, 1 carrying a flag.
- Idun Peptides· 20mg · lot BB20-260706 · Kovera Labs· 107% of labelverify at Kovera Labs One vial measured
Side-effect questions
Side-effect section last reviewed 2026-09-12. Moved from the standalone side-effects page on 10 October 2026; text unchanged.
Supporting Research
Insufficient EvidenceInsufficient — Blend, No Blend-Specific Trials
Evidence note: No clinical trials exist for the Wolverine Stack blend formulation. Individual constituent evidence (BPC-157, TB-500) is preclinical only. Blend synergy claims are theoretical and not supported by any published research.
Wolverine Stack is a proprietary blend of BPC-157 and TB-500. No human or animal clinical trials have been conducted on this specific blend formulation. Evidence for individual constituents is preclinical only.
References
- Sikiric P, et al.PRECLINICAL — BPC-157 constituentCurrent Pharmaceutical Design. 2011. PubMedPreclinical evidence for BPC-157 constituent; does not establish efficacy for the blend formulation.
- Goldstein AL, Hannappel E, Kleinman HK.PRECLINICAL — TB-500 constituentTrends in Molecular Medicine. 2005. PubMedPreclinical evidence for thymosin beta-4 (TB-500 constituent); does not establish efficacy for the blend formulation.
Research Databases
PubMed
Ready to Source Wolverine Blend?
Purgo Labs offers Wolverine Blend with ≥99% purity, third-party certificates of analysis, and fast FedEx shipping. This is an affiliate link — we may earn a commission at no cost to you.